Engineering the MoS(2)/MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens

High‐throughput metabolic fingerprinting has been deemed one of the most promising strategies for addressing the high false positive rate of prostate cancer (PCa) diagnosis in the prostate‐specific antigen (PSA) gray zone. However, the current metabolic fingerprinting remains challenging in achievin...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Shaowei, Fei, Xiaochen, Wang, Jiayi, Zhu, Yi‐Cheng, Liu, Jiazhou, Du, Xinxing, Liu, Xuesong, Dong, Liang, Zhu, Yinjie, Pan, Jiahua, Dong, Baijun, Sha, Jianjun, Luo, Yu, Sun, Wenshe, Xue, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214233/
https://www.ncbi.nlm.nih.gov/pubmed/36988431
http://dx.doi.org/10.1002/advs.202206494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214233/
https://www.ncbi.nlm.nih.gov/pubmed/36988431
http://dx.doi.org/10.1002/advs.202206494

Ejemplares similares